HemaSphere (May 2023)
P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
- K. Groen,
- C. Stege,
- K. Nasserinejad,
- K. de Heer,
- R. van Kampen,
- R. Leys,
- N. Thielen,
- M. Westerman,
- K. Wu,
- I. Ludwig,
- D. Issa,
- G. Velders,
- M. Vekemans,
- N. van de Donk,
- G. Timmers,
- F. de Boer,
- L. Tick,
- E. van der Spek,
- E. de Waal,
- M. Sohne,
- P. Sonneveld,
- I. Nijhof,
- S. Klein,
- M. Levin,
- P. Ypma,
- S. Zweegman
Affiliations
- K. Groen
- 1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
- C. Stege
- 1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
- K. Nasserinejad
- 3 HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- K. de Heer
- 4 Department of Internal Medicine, Flevoziekenhuis, Almere, the Netherlands
- R. van Kampen
- 5 Department of Internal Medicine, Zuyderland Hospital, Sittard-Geleen, the Netherlands
- R. Leys
- 6 Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands
- N. Thielen
- 7 Department of Internal Medicine, Diakonessenhuis, Utrecht, the Netherlands
- M. Westerman
- 8 Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands
- K. Wu
- 9 Department of Hematology, ZNA Stuivenberg, Antwerpen, Belgium
- I. Ludwig
- 10 Department of Internal Medicine, Ziekenhuis Bernhoven, Uden, the Netherlands
- D. Issa
- 11 Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands
- G. Velders
- 12 Department of Internal Medicine, Gelderse Vallei, Ede, the Netherlands
- M. Vekemans
- 13 Department of Hematology, Cliniques universitaires Saint-Luc, UCL, Brussels, Belgium
- N. van de Donk
- 1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
- G. Timmers
- 14 Department of Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands
- F. de Boer
- 15 Department of Internal Medicine, Ikazia Hospital, Rotterdam, the Netherlands
- L. Tick
- 16 Department of Internal Medicine, Maxima Medical Center, Eindhoven, the Netherlands
- E. van der Spek
- 17 Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands
- E. de Waal
- 18 Department of Internal Medicine, Medisch Centrum Leeuwarden, Leeuwarden, the Netherlands
- M. Sohne
- 19 Department of Internal Medicine, Antonius Ziekenhuis, Nieuwegein, the Netherlands
- P. Sonneveld
- 20 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
- I. Nijhof
- 1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
- S. Klein
- 1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
- M. Levin
- 23 Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands
- P. Ypma
- 24 Department of Internal Medicine, Haga Hospital, Den Haag, the Netherlands
- S. Zweegman
- 1 Department of Hematology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
- DOI
- https://doi.org/10.1097/01.HS9.0000936180.78583.90
- Journal volume & issue
-
Vol. 7,
no. S2
pp. 16 – 17
Abstract
No abstracts available.